Manufacturing Execution System Market

Table of Contents

1. BACKGROUND
1.1. Context
1.2. Project Approach

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Overview of Manufacturing Execution Systems
3.2. Core Function of Manufacturing Execution Systems
3.3 Deployment Models of Manufacturing Execution Systems
3.4 Benefits Offered by Manufacturing Execution Systems
3.5 Challenges Associated with Manufacturing Execution Systems
3.6 Integration of Manufacturing Execution Systems for Different Operations
3.7 Concluding Remarks

4. MARKET LANDSCAPE 
4.1. Manufacturing Execution System Providers in Healthcare: Market Overview
4.2. List of Manufacturing Execution System Providers in Healthcare
4.3. Analysis by Year of Establishment
4.4. Analysis by Company Size
4.5. Analysis by Location of Headquarters
4.6. Analysis by Type of Deployment
4.7. Analysis by Integrating Software
4.8. Analysis by Type of License
4.9. Analysis by Type of End User
4.10. Analysis by Key Features
4.11. Analysis by Type of Service(s) Offered
4.12. Analysis by Quality Certifications Received

5. KEY INSIGHTS
5.1. Analysis by Year of Establishment and Region of Headquarters
5.2. Analysis by Company Size and Type of Deployment
5.3. Analysis by Type of License and End User
5.4. Analysis by Company Size and Key Features
5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)

6. PARTNERSHIPS AND COLLABORATIONS 
6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
6.2. Analysis by Year of Partnership
6.3. Analysis by Type of Partnership
6.4. Analysis by Year of Partnership and Type of Partnership
6.5. Analysis by Type of Partnership and Company Size
6.6. Key Players: Analysis by Number of Partnerships
6.7. Analysis by Type of Partner
6.8. Analysis by Country
6.9. Analysis by Region
6.10. Intercontinental and Intracontinental Deals 
6.11. Analysis by Location of Headquarters of Partner
6.12. Analysis by Type of Partnership and Location of Headquarters of Partner 

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Partnership Activity
7.6. Company Competitiveness Analysis: Very Large Players 
7.7. Company Competitiveness Analysis: Large Players 
7.8. Company Competitiveness Analysis: Mid-Sized Players
7.9. Company Competitiveness Analysis: Small Players 

8. COMPANY PROFILES
8.1. Andea
8.1.1 Company Overview
8.1.2. Technology Portfolio
8.1.3. Recent Developments and Future Outlook

8.2. Critical Manufacturing
8.2.1 Company Overview
8.2.2. Technology Portfolio
8.2.3. Recent Developments and Future Outlook

8.3. Dassault Systèmes
8.3.1 Company Overview
8.3.2. Technology Portfolio
8.3.3. Recent Developments and Future Outlook

8.4. GE Digital
8.4.1 Company Overview
8.4.2. Technology Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. Infor
8.5.1 Company Overview
8.5.2. Technology Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. Körber
8.6.1 Company Overview
8.6.2. Technology Portfolio
8.6.3. Recent Developments and Future Outlook

8.7. Rockwell Automation
8.7.1 Company Overview
8.7.2. Technology Portfolio
8.7.3. Recent Developments and Future Outlook

9. VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS
9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
9.2. Key Assumptions and Methodology
9.3. Key Tools and Technologies
9.3.1. Technology 1
9.3.2. Technology 2
9.3.3. Technology 3
9.3.4. Technology 4
9.4. Extent of Innovation versus Associated Risks
9.5 Concluding Remarks

10. MARKET FORECAST
10.1. Key Assumptions and Forecast Methodology
10.2. Forecasted Market Segments 
10.3. Manufacturing Execution System Providers in Healthcare Market, 2022-2035

10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, 2022-2035
10.4.1. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions
10.4.2. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions
10.4.3. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions
10.4.4. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions

10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, 2022-2035
10.5.1. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies
10.5.2. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers
10.5.3. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies
10.5.4. Manufacturing Execution System Providers in Healthcare Market for Other End Users

10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, 2022-2035
10.6.1. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
10.6.2. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
10.6.3. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
10.6.4. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
10.6.5. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
10.6.6. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035

11. EXECUTIVE INSIGHTS 
11.1. NoMuda
11.1.1. Company Snapshot
11.1.2. Interview Transcript: Philip Borland (Chief Executive Officer)

11.2. ORDINAL Software
11.2.1. Company Snapshot
11.2.2. Interview Transcript: Carine van Godtsenhoven (Chief Marketing Officer)

11.3. Trunovate
11.3.1. Company Snapshot
11.3.2. Interview Transcript: Yaron Halfon (Director of Sales)

12. APPENDICES I: OTHER FIGURES
12.1. Market Overview
12.2. Key Insights
12.3. Partnerships and Collaborations
12.4. List of Figures

13. APPENDICES II: TABULATED DATA

14. APPENDICES III: LIST OF COMPANIES

List of Figures

Figure 3.1. Core Function of Manufacturing Execution Systems
Figure 3.2. Deployment Models of Manufacturing Execution Systems
Figure 3.3. Benefits and Challenges of Manufacturing Execution Systems
Figure 3.4. Integration of Manufacturing Execution Systems for Different Operations
Figure 4.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
Figure 4.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
Figure 4.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
Figure 4.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
Figure 4.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
Figure 4.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
Figure 4.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
Figure 4.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
Figure 4.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
Figure 5.1. Key Insights: Distribution by Year of Establishment and Region of Headquarters
Figure 5.2. Key Insights: Distribution by Company Size and Type of Deployment
Figure 5.3. Key Insights: Distribution by Type of License and End User
Figure 5.4. Key Insights: Distribution by Company Size and Key Features
Figure 5.5. Key Insights: Distribution by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received
Figure 6.1. Partnerships and Collaborations: Distribution by Year of Partnership
Figure 6.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3. Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 6.4. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 6.5. Partnerships and Collaborations: Key Players by Number of Partnerships
Figure 6.6. Partnerships and Collaborations: Distribution by Type of Partner
Figure 6.7. Partnerships and Collaborations: Distribution by Country
Figure 6.8. Partnerships and Collaborations: Distribution by Region
Figure 6.9. Intercontinental and Intracontinental Deals
Figure 7.1. Company Competitiveness Analysis: Benchmarking of Portfolio Strength
Figure 7.2. Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 7.3. Company Competitiveness Analysis: Very Large Players
Figure 7.4 .Company Competitiveness Analysis: Large Players
Figure 7.5 .Company Competitiveness Analysis: Mid-Sized Players
Figure 7.6. Company Competitiveness Analysis: Small Players
Figure 9.1. Value Creation Framework: Trends in Research Activity related to Integration of Key Tools and Technologies with Manufacturing Execution System
Figure 9.2. Value Creation Framework: Trends in Intellectual Property related to Integration of Key Tools and Technologies with Manufacturing Execution System
Figure 9.3. Value Creation Framework: Extent of Innovation versus Associated Risk Matrix
Figure 9.4. Value Creation Framework: Comparison of Key Tools / Technologies
Figure 10.1. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, 2022-2035
Figure 10.2. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
Figure 10.3. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
Figure 10.4. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
Figure 10.5. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
Figure 10.6. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, 2022-2035
Figure 10.7. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
Figure 10.8. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
Figure 10.9. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
Figure 10.10. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
Figure 10.11. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, 2022-2035
Figure 10.12. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
Figure 10.13. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
Figure 10.14. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
Figure 10.15. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
Figure 10.16. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
Figure 10.17. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035

List of Tables

Table 4.1. Manufacturing Execution System Providers in Healthcare: Information on Year of Establishment, Headquarters, Company Size and Name of Solution
Table 4.2. Manufacturing Execution System Providers in Healthcare: Information on Type of Deployment, Integrating Software, Type of License, Type of End User, Key Features, Type of Service(s) Offered and Quality Certifications Received
Table 4.3. Manufacturing Execution System Providers in Healthcare: Key Features, Type of Service(s) Offered and Quality Certifications Received
Table 6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
Table 13.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
Table 13.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
Table 13.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
Table 13.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
Table 13.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
Table 13.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
Table 13.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
Table 13.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
Table 13.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
Table 13.10. Partnerships and Collaborations: Distribution by Year of Partnership
Table 13.11. Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.12. Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.13. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 13.14. Partnerships and Collaborations: Key Players by Number of Partnerships
Table 13.15. Partnerships and Collaborations: Distribution by Type of Partner
Table 13.16. Partnerships and Collaborations: Distribution by Country
Table 13.17. Partnerships and Collaborations: Distribution by Region
Table 13.18. Intercontinental and Intracontinental Deals
Table 13.19. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, 2022-2035
Table 13.20. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
Table 13.21. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
Table 13.22. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
Table 13.23. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
Table 13.24. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, 2022-2035
Table 13.25. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
Table 13.26. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
Table 13.27. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
Table 13.28. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
Table 13.29. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, 2022-2035
Table 13.30. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
Table 13.31. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
Table 13.32. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
Table 13.33. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
Table 13.34. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
Table 13.35. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035

List of Companies

Please reach out to our team for the details.